Randomised Trials in percutaneous treatment for structural heart disease
On this page you will find a list of randomised trials in percutaneous treatment for structural heart disease, published in some of the world's top cardiology and interventional cardiology journals.
Residual leaks following percutaneous left atrial appendage occlusion: assessment and management implications
A common clinical dilemma is the management of patients with peri-device leak after LAA occlusion. The specific definitions of leak severity, and the longer-term clinical implications are poorly understood.
Complex LAA closure interventions
Access to commented cases presented at EuroPCR 2017. Listen to your peers explaining how they managed particularly complicated cases. Discover their "tricks" to prevent catheter bleeding or perform LAA closure in complex anatomy and more.
3D printing for LAA closure - EuroIntervention
Device sizing for LAA closure using transoesophageal echocardiography (TEE) can be challenging due to complex LAA anatomy. Michaela M. Hell and team investigated whether the use of 3D-printed left atrial appendage (LAA) models based on preprocedural computed tomography (CT) permits accurate device sizing.
Printed MDCT 3D models for prediction of left atrial appendage (LAA) occluder device size: a feasibility study
The AMPLATZER™ Amulet™ – facing the challenge of left atrial appendage occlusion
Over the last decade left atrial appendage occlusion has been a topic of intense clinical research
PFO closure reduces recurrent strokes – a therapeutic promise is finally kept
22 May 2017
In patients with a patent foramen ovale (PFO) and cryptogenic stroke, percutaneous closure of the PFO has long been postulated to reduce the rate of recurrent strokes. However, up until now, trial data has failed to convincingly deliver a message of benefit for such an approach. Although the wait has been long, two recently reported trials finally seem to deliver on the therapeutic promise of PFO closure.
EuroPCR 2017 Highlights: Interventions for Stroke
20 May 2017 - From EUROPCR 2017
Interventional treatment of stroke is the future! M. Roffi and Ö. Göktekin along with L. N. Hopkins, neurosurgeon, explain how interventional cardiologists can respond to this challenge. Robust data supporting mechanical treatment of acute stroke increases daily. Until recently we believed intervention worked only within a 6 hour window, but now, the newly released DAWN trial shows that patient selection, IV r-tPA + clot retrieval can have a positive benefit for up to 24 hours after a stroke. An army of interventionalists is needed to treat the millions of eligible patients!
19 May 2017 – From EuroPCR 2017
Consult this session on LAA closure, that includes a LIVE demonstration from the Cardiovascular Centre, OLV Aalst - Aalst, Belgium.
Moderated posters - session 3
18 May 2017 – From EuroPCR 2017